Arcturus Therapeutics Holdings Inc. SEC filings ARCT
Arcturus Therapeutics Holdings Inc. has 416 filings in SEC EDGAR's recent list, going back to Mar 18, 2019. Its latest annual report, Form 10-K, was filed on Mar 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Dec 30, 2025 | — |
| S-8 | Employee stock plan registration | Jul 17, 2024 | — |
| 424B5 | Prospectus supplement | Aug 7, 2023 | — |
| S-3 | Shelf registration | Dec 23, 2022 | — |
| S-8 | Employee stock plan registration | Jun 30, 2022 | — |
| S-8 | Employee stock plan registration | Oct 20, 2021 | — |
| 424B5 | Prospectus supplement | Dec 8, 2020 | — |
| 424B5 | Prospectus supplement | Dec 7, 2020 | — |
| S-3ASR | Automatic shelf registration | Dec 7, 2020 | — |
| S-8 | Employee stock plan registration | Aug 5, 2020 | — |
| S-8 | Employee stock plan registration | Aug 5, 2020 | — |
| 424B5 | Prospectus supplement | Jul 30, 2020 | — |
| 424B5 | Prospectus supplement | Jul 28, 2020 | — |
| S-3/A | Filing | May 22, 2020 | — |
| S-3 | Shelf registration | May 8, 2020 | — |
| 424B5 | Prospectus supplement | Apr 17, 2020 | — |
| S-3MEF | Filing | Apr 16, 2020 | — |
| 424B5 | Prospectus supplement | Apr 15, 2020 | — |
| 424B5 | Prospectus supplement | Mar 27, 2020 | — |
| S-3 | Shelf registration | Dec 12, 2019 | — |
| 424B5 | Prospectus supplement | Sep 27, 2019 | — |
| 424B5 | Prospectus supplement | Aug 5, 2019 | — |
| 424B5 | Prospectus supplement | Aug 2, 2019 | — |
| S-3/A | Filing | Jun 26, 2019 | — |
| S-3 | Shelf registration | Jun 21, 2019 | — |
| S-8 | Employee stock plan registration | Jun 21, 2019 | — |
| 424B3 | Prospectus | Apr 12, 2019 | — |
| S-4/A | Filing | Apr 11, 2019 | — |
| S-4 | Registration for a merger or exchange | Mar 18, 2019 | — |
Showing 29 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ARCT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1768224
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.